Pharmaceuticals, Biotechnology and Life Sciences
ZYUS to leverage Revon’s proprietary technology platform in clinical studies and trials of innovative product candidates SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life…
HALIFAX, Nova Scotia–(BUSINESS WIRE)–$IMV #AntibioticDeveloper–Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it will issue a press release on its…
LOUISVILLE, Ky.–(BUSINESS WIRE)–Onco360®, the nation’s largest independent Oncology Pharmacy, announced today that it was selected to be a specialty pharmacy…
The award-winner of the 2019 Hansen Family Award is Professor Edith Heard. The Board of Trustees of the Bayer Science & Education Foundation and the Scientific Committee for this award have presented her with one of Germany’s most prestigious scientific accolades including a prize money of EUR 75,000.
Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, presented updated interim results from the biliary cancer cohort of SUMMIT, an ongoing Phase II basket trial examining the efficacy of neratinib in HER2-mutated cancers
– ULTOMIRIS has the potential to become the new standard of care for both complement inhibitor-naïve patients and patients switching from SOLIRIS® (eculizumab) –
ZYUS to leverage Revon’s proprietary technology platform in clinical studies and trials of innovative product candidates SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life…
LabShares, MassCONNECT and the MTTC awarded L Stem Prize at MALSI Day NEWTON, Mass.–(BUSINESS WIRE)–LabShares Newton, a shared office and…
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), the global biotechnology leader in rare diseases, will present research covering a broad range of rare bleeding disorders at the 27th Annual International Society on Thrombosis and Haemostasis Congress